Farfetch Ltd
F:F1F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Farfetch Ltd
F:F1F
|
UK |
|
Floridienne SA
F:OI9
|
BE |
|
S
|
Sanofi SA
LSE:0O59
|
FR |
|
E
|
Enzon Pharmaceuticals Inc
SWB:EZ1
|
US |
|
B
|
Black Sea Property AS
OSE:BSP
|
NO |
|
E
|
Eugene Investment & Securities Co Ltd
KRX:001200
|
KR |
|
T
|
Taihan Textile Co Ltd
KRX:001070
|
KR |
|
Z
|
Zhejiang Bangjie Holding Group Co Ltd
SZSE:002634
|
CN |
|
D&G Technology Holding Co Ltd
HKEX:1301
|
CN |
|
M
|
Maywood Acquisition Corp
NASDAQ:MAYA
|
US |
|
Isofol Medical AB (publ)
STO:ISOFOL
|
SE |
|
V
|
Voyant International Corp
OTC:VOYT
|
US |
|
Brother Industries Ltd
OTC:BRTHF
|
JP |
|
Z
|
Zhejiang Changhua Auto Parts Co Ltd
SSE:605018
|
CN |
|
Gentera SAB de CV
OTC:CMPRF
|
MX |
Balance Sheet
Balance Sheet Decomposition
Farfetch Ltd
Farfetch Ltd
Balance Sheet
Farfetch Ltd
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
150
|
384
|
1 045
|
322
|
1 573
|
1 363
|
734
|
|
| Cash Equivalents |
150
|
384
|
1 045
|
322
|
1 573
|
1 363
|
734
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
100
|
0
|
|
| Total Receivables |
12
|
11
|
59
|
172
|
200
|
360
|
447
|
|
| Accounts Receivables |
0
|
0
|
0
|
34
|
50
|
63
|
90
|
|
| Other Receivables |
0
|
0
|
0
|
137
|
150
|
297
|
358
|
|
| Inventory |
14
|
51
|
61
|
128
|
145
|
256
|
346
|
|
| Other Current Assets |
6
|
8
|
35
|
23
|
42
|
33
|
62
|
|
| Total Current Assets |
181
|
453
|
1 199
|
645
|
1 961
|
2 112
|
1 589
|
|
| PP&E Net |
16
|
27
|
38
|
183
|
268
|
293
|
279
|
|
| PP&E Gross |
16
|
27
|
38
|
183
|
268
|
293
|
279
|
|
| Accumulated Depreciation |
6
|
9
|
15
|
23
|
37
|
46
|
65
|
|
| Intangible Assets |
17
|
36
|
67
|
1 022
|
923
|
977
|
1 146
|
|
| Goodwill |
26
|
38
|
36
|
341
|
357
|
382
|
402
|
|
| Note Receivable |
5
|
9
|
11
|
12
|
58
|
31
|
21
|
|
| Long-Term Investments |
0
|
0
|
1
|
19
|
11
|
18
|
219
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
5
|
14
|
13
|
20
|
|
| Other Assets |
26
|
38
|
36
|
341
|
357
|
382
|
402
|
|
| Total Assets |
245
N/A
|
563
+130%
|
1 351
+140%
|
2 228
+65%
|
3 591
+61%
|
3 827
+7%
|
3 676
-4%
|
|
| Liabilities | ||||||||
| Accounts Payable |
58
|
81
|
102
|
180
|
278
|
343
|
311
|
|
| Accrued Liabilities |
25
|
55
|
90
|
180
|
302
|
320
|
315
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
3
|
0
|
0
|
19
|
26
|
34
|
37
|
|
| Other Current Liabilities |
3
|
21
|
2
|
90
|
173
|
211
|
220
|
|
| Total Current Liabilities |
89
|
156
|
194
|
468
|
779
|
907
|
883
|
|
| Long-Term Debt |
17
|
0
|
0
|
101
|
783
|
697
|
1 071
|
|
| Deferred Income Tax |
0
|
0
|
0
|
220
|
183
|
156
|
127
|
|
| Minority Interest |
0
|
0
|
0
|
170
|
169
|
182
|
157
|
|
| Other Liabilities |
19
|
10
|
29
|
101
|
3 505
|
1 796
|
689
|
|
| Total Liabilities |
126
N/A
|
166
+32%
|
223
+34%
|
1 060
+375%
|
5 418
+411%
|
3 738
-31%
|
2 928
-22%
|
|
| Equity | ||||||||
| Common Stock |
6
|
7
|
12
|
14
|
14
|
15
|
16
|
|
| Retained Earnings |
197
|
291
|
368
|
307
|
2 762
|
1 544
|
917
|
|
| Additional Paid In Capital |
343
|
680
|
772
|
878
|
928
|
1 642
|
1 686
|
|
| Other Equity |
33
|
1
|
24
|
31
|
7
|
25
|
37
|
|
| Total Equity |
119
N/A
|
397
+234%
|
1 128
+184%
|
1 168
+3%
|
1 827
N/A
|
89
N/A
|
748
+744%
|
|
| Total Liabilities & Equity |
245
N/A
|
563
+130%
|
1 351
+140%
|
2 228
+65%
|
3 591
+61%
|
3 827
+7%
|
3 676
-4%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
293
|
293
|
300
|
340
|
354
|
381
|
395
|
|